Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev ® ) in South Korea, 2015–2019

ConclusionJE-CV has a good safety profile under practice conditions in South Korea. No new safety issues were identified.Trial registrationClinicalTrials.gov identifier, NCT02933710
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research